Tuesday, Biogen Idec Inc. (BIIB) said its fourth-quarter net income attributable to Biogen Idec Inc. increased to $305.63 million or $1.06 per share from $206.65 million or $0.70 per share in the prior year period.
Non-GAAP net income attributable to Biogen Idec, Inc. grew to $345.2 million or $1.20 per share from $274.3 million or $0.93 per share in the year-ago period. On average, 20 analysts polled by Thomson Reuters expected the company to report earnings of $1.05 per share for the quarter.
Total revenues for the quarter rose to $1.12 billion from $1.06 billion in the comparable period. Eighteen analysts estimated revenues of $1.13 billion for the quarter.
For fiscal 2010, the company's GAAP earnings per share are expected to be above $3.71 and non-GAAP earnings per share are projected to be above $4.55. Revenue growth in 2010 is anticipated to be in the mid single digits. Twenty analysts estimate earnings of $4.37 per share and sixteen analysts estimate revenues of $4.51 billion for the year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.